Journal of Cachexia Sarcopenia and Muscle
News
11 May 2023
- In a groundbreaking study, Professor Yea’s DGIST research
team verified the effectiveness of the anti-GFRAL human
antibodies in improving chemotherapy-induced cancer cachexia
- The team presents a candidate antibody for managing cancer cachexia, a condition without an approved and effective
therapy worldwide